Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

In vitro bioassays are better than traditional methods for measuring androgen activity but aren't ready for routine use yet.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

New compounds with carborane showed anti-androgen effects similar to flutamide.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Menthol-based microemulsions improve skin delivery of finasteride and silodosin.

Analog 23 is a promising compound for prostate cancer treatment.

The formulation with oleic acid may be better for treating male pattern baldness.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

5% ET-02 is a more effective and safe treatment for hair loss than current options.

Clascoterone may be an effective topical treatment for hair loss.

Isoproterenol may help treat hair loss by activating hair follicle stem cells.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

The new testosterone patch works as well as the gel.

The assay effectively detects hormonal activity of certain chemicals.

The treatment slightly increased hair growth and was safe for most women.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Phyto-vesicles of β-sitosterol may effectively treat hair loss.